Cargando…
SubmiRine: assessing variants in microRNA targets using clinical genomic data sets
MicroRNAs (miRNAs) regulate gene expression by binding to partially complementary sequences on target mRNA transcripts, thereby causing their degradation, deadenylation, or inhibiting their translation. Genomic variants can alter miRNA regulation by modifying miRNA target sites, and multiple human d...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417167/ https://www.ncbi.nlm.nih.gov/pubmed/25813044 http://dx.doi.org/10.1093/nar/gkv256 |
_version_ | 1782369321182298112 |
---|---|
author | Maxwell, Evan K. Campbell, Joshua D. Spira, Avrum Baxevanis, Andreas D. |
author_facet | Maxwell, Evan K. Campbell, Joshua D. Spira, Avrum Baxevanis, Andreas D. |
author_sort | Maxwell, Evan K. |
collection | PubMed |
description | MicroRNAs (miRNAs) regulate gene expression by binding to partially complementary sequences on target mRNA transcripts, thereby causing their degradation, deadenylation, or inhibiting their translation. Genomic variants can alter miRNA regulation by modifying miRNA target sites, and multiple human disease phenotypes have been linked to such miRNA target site variants (miR-TSVs). However, systematic genome-wide identification of functional miR-TSVs is difficult due to high false positive rates; functional miRNA recognition sequences can be as short as six nucleotides, with the human genome encoding thousands of miRNAs. Furthermore, while large-scale clinical genomic data sets are becoming increasingly commonplace, existing miR-TSV prediction methods are not designed to analyze these data. Here, we present an open-source tool called SubmiRine that is designed to perform efficient miR-TSV prediction systematically on variants identified in novel clinical genomic data sets. Most importantly, SubmiRine allows for the prioritization of predicted miR-TSVs according to their relative probability of being functional. We present the results of SubmiRine using integrated clinical genomic data from a large-scale cohort study on chronic obstructive pulmonary disease (COPD), making a number of high-scoring, novel miR-TSV predictions. We also demonstrate SubmiRine's ability to predict and prioritize known miR-TSVs that have undergone experimental validation in previous studies. |
format | Online Article Text |
id | pubmed-4417167 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-44171672015-05-12 SubmiRine: assessing variants in microRNA targets using clinical genomic data sets Maxwell, Evan K. Campbell, Joshua D. Spira, Avrum Baxevanis, Andreas D. Nucleic Acids Res Computational Biology MicroRNAs (miRNAs) regulate gene expression by binding to partially complementary sequences on target mRNA transcripts, thereby causing their degradation, deadenylation, or inhibiting their translation. Genomic variants can alter miRNA regulation by modifying miRNA target sites, and multiple human disease phenotypes have been linked to such miRNA target site variants (miR-TSVs). However, systematic genome-wide identification of functional miR-TSVs is difficult due to high false positive rates; functional miRNA recognition sequences can be as short as six nucleotides, with the human genome encoding thousands of miRNAs. Furthermore, while large-scale clinical genomic data sets are becoming increasingly commonplace, existing miR-TSV prediction methods are not designed to analyze these data. Here, we present an open-source tool called SubmiRine that is designed to perform efficient miR-TSV prediction systematically on variants identified in novel clinical genomic data sets. Most importantly, SubmiRine allows for the prioritization of predicted miR-TSVs according to their relative probability of being functional. We present the results of SubmiRine using integrated clinical genomic data from a large-scale cohort study on chronic obstructive pulmonary disease (COPD), making a number of high-scoring, novel miR-TSV predictions. We also demonstrate SubmiRine's ability to predict and prioritize known miR-TSVs that have undergone experimental validation in previous studies. Oxford University Press 2015-04-30 2015-03-26 /pmc/articles/PMC4417167/ /pubmed/25813044 http://dx.doi.org/10.1093/nar/gkv256 Text en Published by Oxford University Press on behalf of Nucleic Acids Research 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US. |
spellingShingle | Computational Biology Maxwell, Evan K. Campbell, Joshua D. Spira, Avrum Baxevanis, Andreas D. SubmiRine: assessing variants in microRNA targets using clinical genomic data sets |
title | SubmiRine: assessing variants in microRNA targets using clinical genomic data sets |
title_full | SubmiRine: assessing variants in microRNA targets using clinical genomic data sets |
title_fullStr | SubmiRine: assessing variants in microRNA targets using clinical genomic data sets |
title_full_unstemmed | SubmiRine: assessing variants in microRNA targets using clinical genomic data sets |
title_short | SubmiRine: assessing variants in microRNA targets using clinical genomic data sets |
title_sort | submirine: assessing variants in microrna targets using clinical genomic data sets |
topic | Computational Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417167/ https://www.ncbi.nlm.nih.gov/pubmed/25813044 http://dx.doi.org/10.1093/nar/gkv256 |
work_keys_str_mv | AT maxwellevank submirineassessingvariantsinmicrornatargetsusingclinicalgenomicdatasets AT campbelljoshuad submirineassessingvariantsinmicrornatargetsusingclinicalgenomicdatasets AT spiraavrum submirineassessingvariantsinmicrornatargetsusingclinicalgenomicdatasets AT baxevanisandreasd submirineassessingvariantsinmicrornatargetsusingclinicalgenomicdatasets |